Marilu Fiegenbaum

The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment

Marilu Fiegenbaum, F DASILVEIRA, C VANDERSAND et al. · Clinical Pharmacology & Therapeutics · 2005 · 214 citations

Low-grade inflammation markers in children and adolescents: Influence of anthropometric characteristics and CRP and IL6 polymorphisms

Pâmela Ferreira Todendi, Lia Gonçalves Possuelo, Elisa Inês Klinger et al. · Cytokine · 2016 · 42 citations

Pharmacogenetic study of apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase genes and simvastatin therapy in Brazilian subjects

Marilu Fiegenbaum, Fabiano Roldao Silveira, Cézar Roberto Van Der Sand et al. · Clinica Chimica Acta · 2005 · 40 citations

Brazilian Subjects, Apolipoprotein E, Oxysterol +8

Determinants of variable response to simvastatin treatment: the role of common variants of SCAP, SREBF-1a and SREBF-2 genes

Marilu Fiegenbaum, Fabiano Roldao Silveira, Cézar Roberto Van Der Sand et al. · The Pharmacogenomics Journal · 2005 · 38 citations

Inflammation, Variable Response, Translational Medicine +9

Association of GPX1 and GPX4 polymorphisms with episodic memory and Alzheimer’s disease

Tatiane Jacobsen da Rocha, Mônica Silva Alves, Carolina Campelo Guisso et al. · Neuroscience Letters · 2017 · 36 citations

Neurodegenerative Diseases, Alzheimer's Disease, Medicine +10